We are live on ! Find out more
TA

Tamarack Advisers Portfolio holdings

AUM $2.12M
1-Year Est. Return 58.09%
This Fund
S&P 500
This Quarter Est. Return
+22.63%
1 Year Est. Return
-58.09%
3 Year Est. Return
-46.51%
5 Year Est. Return
+44.44%
10 Year Est. Return
–
AUM
$480M
AUM Growth
+$155M
Cap. Flow
+$85.5M
Cap. Flow %
17.81%
Top 10 Hldgs %
55.71%
Holding
53
New
19
Increased
14
Reduced
7
Closed
9

Top Buys

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$13.8M
2
SNRHU
Senior Connect Acquisition Corp. I Unit
SNRHU
+$9.8M
3
OPEN icon
Opendoor
OPEN
+$9.75M
4
VRTX icon
Vertex Pharmaceuticals
VRTX
+$9.64M
5
NUAN
Nuance Communications, Inc.
NUAN
+$8.53M

Top Sells

Rank Stock Value
1
BIO icon
Bio-Rad Laboratories Class A
BIO
+$7.73M
2
AHCO icon
AdaptHealth
AHCO
+$6.65M
3
PHR icon
Phreesia
PHR
+$5.36M
4
MDRX
Veradigm Inc. Common Stock
MDRX
+$4.84M
5
PLXS icon
Plexus
PLXS
+$3.36M

Sector Composition

Rank Sector Weight
1 Healthcare 82.05%
2 Technology 6.99%
3 Consumer Staples 3.31%
4 Real Estate 1.49%
5 Consumer Discretionary 1.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ITGR icon
26
Integer Holdings
ITGR
$4.12B
$5.84M 1.22%
+74,000
New +$5.19M
ISEE
27
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$5.81M 1.21%
850,000
-50,000
-6% -$320K
ANGO icon
28
AngioDynamics
ANGO
$611M
$5.56M 1.16%
+360,000
New +$4.57M
PLNT icon
29
Planet Fitness
PLNT
$4.42B
$5.55M 1.16%
+75,000
New +$5.25M
EW icon
30
Edwards Lifesciences
EW
$49.6B
$4.42M 0.92%
50,000
– –
GLD icon
31
CALL
SPDR Gold Trust
GLD
$131B
$4.2M 0.88%
+6,000
New +$1.06M
INMD icon
32
InMode
INMD
$870M
$4.14M 0.86%
+180,000
New +$3.8M
MSON
33
DELISTED
Misonix Inc
MSON
$3.76M 0.78%
300,000
– –
TRHC
34
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
$3.34M 0.7%
+80,000
New +$3.04M
CLVR
35
DELISTED
Clever Leaves Holdings Inc. Common Shares
CLVR
$2.64M 0.55%
+10,000
New +$3.24M
OEF icon
36
PUT
iShares S&P 100 ETF
OEF
$20.1B
$2.42M 0.5%
5,000
+1,000
+25% +$163K
VTRS icon
37
CALL
Viatris
VTRS
$20.4B
$1.88M 0.39%
+5,000
New +$81.6K
MRVI icon
38
Maravai LifeSciences
MRVI
$969M
$1.37M 0.29%
+50,000
New +$1.39M
SRSA
39
DELISTED
Sarissa Capital Acquisition Corp. Class A Ordinary Shares
SRSA
$1.35M 0.28%
+125,000
New +$1.28M
DMTK
40
DELISTED
DermTech, Inc. Common Stock
DMTK
$798K 0.17%
+25,000
New +$354K
JNJ icon
41
CALL
Johnson & Johnson
JNJ
$618B
$785K 0.16%
+4,000
New +$590K
MAPS
42
DELISTED
WM TECHNOLOGY INC A
MAPS
$651K 0.14%
+50,000
New +$539K
TNDM icon
43
PUT
Tandem Diabetes Care
TNDM
$1.34B
$180K 0.04%
+1,500
New +$155K
PRGO icon
44
CALL
Perrigo
PRGO
$1.4B
$15K ﹤0.01%
+1,500
New +$69.5K
AHCO icon
45
AdaptHealth
AHCO
$1.47B
– –
-305,000
Closed -$6.65M
ALGN icon
46
Align Technology
ALGN
$12.1B
– –
-5,000
Closed -$1.64M
BIO icon
47
Bio-Rad Laboratories Class A
BIO
$8.71B
– –
-15,000
Closed -$7.73M
MDT icon
48
CALL
Medtronic
MDT
$109B
– –
-2,000
Closed -$334K
QDEL icon
49
QuidelOrtho
QDEL
$1.14B
– –
-10,000
Closed -$2.19M
TPB icon
50
CALL
Turning Point Brands
TPB
$1.45B
– –
-1,000
Closed -$52K
1
2
3

Similar funds

SCM
SevenOneSeven Capital Management Lancaster, Pennsylvania $2.17M AUM 8.67% 1-Year Est. Return
LBC
Lawrence B. Cohen $2.06M AUM 34.47% 1-Year Est. Return
ICM
ISZO Capital Management New York $2M AUM 35.61% 1-Year Est. Return
LCMP
Linse Capital Management PR San Juan, Puerto Rico $2.31M AUM
GIP
General Industrial Partners London, United Kingdom $2.57M AUM
STC
Sarah T. Connolly $1.11M AUM 24.13% 1-Year Est. Return
GC
Gilfoyle & Co San Francisco, California $671K AUM
DU
Delphia (USA) Toronto, Ontario, Canada $445K AUM 28.82% 1-Year Est. Return

Tamarack Advisers's Q4 2020 Portfolio in Review

As of Q4 2020, Tamarack Advisers held 53 positions worth $480M, up 48% from $324M the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Tamarack Advisers deployed $85.5M of net new capital in Q4 2020, opening 19 new positions and adding to 14 existing holdings. Its largest new stake was Senior Connect Acquisition Corp. I Unit: 950,000 shares worth $9.84M.

By sector, the portfolio is most concentrated in Healthcare at 82% of assets, down from 90% a quarter earlier, followed by Technology and Consumer Staples.

On the sell side, the largest reduction was Phreesia, an estimated $5.36M trimmed.

  • Tamarack Advisers's largest Q4 2020 buy was Senior Connect Acquisition Corp. I Unit: 950,000 shares worth $9.84M.
  • Tamarack Advisers added most to Medtronic in Q4 2020, an estimated $13.8M increase.
  • Tamarack Advisers's biggest Q4 2020 reduction was Phreesia, cutting an estimated $5.36M.
  • Tamarack Advisers fully exited Bio-Rad Laboratories Class A in Q4 2020, selling an estimated $7.73M.
  • Tamarack Advisers's ten largest holdings make up 56% of its $480M portfolio in Q4 2020.
  • Tamarack Advisers opened 19 new positions and closed 9 in Q4 2020.
  • Tamarack Advisers's portfolio value rose 48% quarter-over-quarter to $480M.

Based on Tamarack Advisers's 13F filing for Q4 2020, filed 10 Feb 2021.